Titanium-prepared Platelet Rich Fibrin Versus Connective Tissue Graft for Management of Type-2 Gingival Recession
NCT ID: NCT06621433
Last Updated: 2024-10-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
44 participants
INTERVENTIONAL
2023-01-01
2024-01-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Use of Platelet Rich Fibrin in Addition to CAF and SCTG for Treatment of Gingival Recession
NCT03199118
Clinical Evaluation of (TCAF) Versus (CAF) Combined With Connective Tissue Graft in the Treatment of Multiple RT2 Gingival Recession Sites
NCT07064603
Platelet-rich Fibrin and Connective Tissue Graft in Recession Treatment
NCT02397122
Treatment of Gingival Recession With Tunnel Technique Using Connective Tissue Graft and Injectable Platelet Rich Fibrin
NCT06646432
Platelet Rich Fibrin in the Treatment of Localized Gingival Recessions
NCT01793389
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Coronally advanced flap (CAF) in conjunction with titanium prepared PRF
T-PRF with CAF
Blood sample will be obtained from the patient, conveyed into a titanium tube and immediately centrifuged at 2700 rpm for 12 mins at room temperature using fixed angle centrifuge (PRF Process, Tangkula800-1, China). The fibrin clot will be collected and placed in the PRF compression device (PRF GRF box) and condensed to produce a uniform T-PRF membrane which will be inserted over the recession area and covered by the coronally advanced flap.
CAF in conjunction with subepithelial connective tissue graft (SECTG)
SECTG with CAF
Sub epithelial connective tissue graft will be obtained from the donor site (hard palate), placed into recipient site and secured by sutures, then covered by a coronally advanced flap.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
T-PRF with CAF
Blood sample will be obtained from the patient, conveyed into a titanium tube and immediately centrifuged at 2700 rpm for 12 mins at room temperature using fixed angle centrifuge (PRF Process, Tangkula800-1, China). The fibrin clot will be collected and placed in the PRF compression device (PRF GRF box) and condensed to produce a uniform T-PRF membrane which will be inserted over the recession area and covered by the coronally advanced flap.
SECTG with CAF
Sub epithelial connective tissue graft will be obtained from the donor site (hard palate), placed into recipient site and secured by sutures, then covered by a coronally advanced flap.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adequate amount of Attached Gingiva (AG) (2 mm≤ AG).
* Good oral hygiene (full mouth bleeding score and O'Leary index less than ≤10 % after complete phase I therapy)
* Clinically thick gingival biotype (1mm \< gingival thickness).
* Anterior esthetic zone.
Exclusion Criteria
* Inadequate amount of attached gingiva (AG \< 2 mm).
* Uncooperative patients.
* Smoking more than 10 cigarettes per day.
* Patients with known systemic conditions or taking medications that may affect soft tissue healing.
* Pregnant and lactating women.
* Patients with parafunctional habits.
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rizk Beshir
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rizk Beshir
MSc. candidate of periodontology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Dentistry, Alexandria University
Alexandria, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1/1-2023
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.